Mubadala Capital-Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
21
- Investments
-
114
- Portfolio
-
67
- Exits
-
16
Mubadala Capital-Ventures General Information
Description
Founded in 2017, Mubadala Capital - Ventures is the venture capital arm of Mubadala Capital, a division of Mubadala Investment Company, a sovereign wealth fund based in Abu Dhabi, United Arab Emirates. The firm seeks to invest in the enterprise, cloud, logistics, mobility, tech-enabled healthcare, fintech, insure tech, consumer, and marketplace sectors preferably across North America, Europe, the Middle East, and North Africa.
Contact Information
Year Founded
2017
Investor Status
Actively Seeking New Investments
Trade Association
British Venture Capital Association (BRVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Fund of Funds
Primary Office
- Mamoura buildings, Near Muroor (4th) Road & Mohammed
- Bin Khalifa (15th) Street
- Abu Dhabi United Arab Emirates
+971 02 000 0000
Mubadala Capital-Ventures Investments (114)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Paradigm (Drug Discovery) | 27-Jan-2023 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue | 0000 000000 |
| 000000000 00000000 | 25-Jan-2023 | 00000 00000 | 0000 | Therapeutic Devices | Startup | |
| 0000 000000000000 | 08-Dec-2022 | 0000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 0000000000 |
| 0000 0000000 | 09-Nov-2022 | 00000 00000 | 0000 | Financial Software | Generating Revenue | 00000000 0000000 |
| 000000 00000000000 | 08-Nov-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 0000000000 |
| 0000000 | 11-Oct-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 0000 000000 |
| 00000 000000000000 | 16-Sep-2022 | 00000 00000 | 000.00 | Discovery Tools (Healthcare) | Generating Revenue | 0000 000000 |
| 0000000 0000000000 | 12-Sep-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 000000 |
| Freeze-Dry Foods | 22-Aug-2022 | Buyout/LBO | Food Products | Generating Revenue | ||
| Unlearn | 16-Aug-2022 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue |
Mubadala Capital-Ventures Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Parkside (Brokerage) | 19-Oct-2022 | Out of Business | |
| 00000 | 01-Jun-2022 | 0000000000 | 00000 |
| 00000 | 04-Jan-2022 | 000000000000000000 | 00000 |
| 0000 | 22-Nov-2021 | 000000000000000000 | 00000 |
| 000000 000000 | 09-Nov-2021 | 0000000 000000 | 00000 |
| 000000 00000000 | 26-Oct-2021 | 000000 0000000000 | 00.000 |
| 00-00000 | 06-Oct-2021 | 000000 0000000000 | 00.00 |
| 0000000 00 | 01-Oct-2021 | 0000000 000000 | 00000 |
| IonQ | 30-Sep-2021 | Reverse Merger | 00000 |
| Ciitizen | 14-Sep-2021 | Merger/Acquisition | 00000 |
Mubadala Capital-Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Mubadala Capital-Ventures Team (26)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Khaled Awad | Chief Financial Officer | Abu Dhabi, United Arab Emirates | |||
| Abdulla AlBanna | Venture Partner | 0 | 0 | 0 | Abu Dhabi, United Arab Emirates |
| James Peck | Partner & Head of Operations | London, United Kingdom | |||
| Frederic Lardieg | Partner | 00 | 0 | 0 | London, United Kingdom |
| Jonno Elliott | Partner | Abu Dhabi, United Arab Emirates |
Mubadala Capital-Ventures Co-Investors (593)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 8 | 0 | 0 |
|
|
| SoftBank Investment Advisers | 0 | 0 | 0 |
|
|
| ARCH Venture Partners | 0 | 0 |
|
|
|
| Felicis Ventures | 0 | 0 |
|
|
|
| 8VC | 0 | 0 | 0 |
|
|